FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Salem school bars church youth leader after student objects to religious conversation|
|A church youth leader has been barred from volunteering at a Salem public school after a student said he was promoting Christianity and insulted her for being an atheist.|
|Seattle megachurch dissolves, weeks after embattled founder resigns under fire|
|Seattle megachurch Mars Hill has dissolved, about two weeks after its founder Mark Driscoll resigned amid questions about his leadership.|
|Excommunicated leader of Mormon women's group loses appeal|
|The founder of a Mormon women's group who was excommunicated this summer says she has lost her appeal.|
|Jury sides with former university official in federal civil rights lawsuit alleging sex abuse|
|A jury says a former university administrator in northeastern Pennsylvania isn't guilty of allegations that he sexually harassed or assaulted students.|
|Jury recommends death penalty for Ohio man convicted of couple's sledgehammer slayings|
|A man who was convicted of beating his girlfriend's parents to death with a sledgehammer should be executed, a jury said Friday.|
|Prosecutor drops charge in death of prayer group leader's wife, says confession unreliable|
|A Missouri prosecutor has dropped charges against a former suburban Kansas City man who confessed to killing the wife of his prayer group leader.|
|Ex-band FAMU member convicted in hazing death|
|A former Florida A&M band member accused of being the ringleader of a brutal hazing ritual known as "Crossing Bus C" that killed a drum major was convicted Friday of manslaughter and felony hazing.|
|Intruder dressed as Grim Reaper attacks woman in her San Diego County home|
|A San Diego County woman has been attacked and stabbed in her home by an intruder dressed as the Grim Reaper on Halloween.|
|Jury convicts California man of murder after hearing 'Hoarders' psychologist's testimony|
|A jury convicted a Northern California man of first-degree murder in the killing of an animal control officer, rejecting testimony from a psychologist who stars on the reality show "Hoarders" that the defendant's hoarding disorder could have made him react violently to anyone trying to take his pets.|
|State police kept slain trooper's handcuffs on the ready to use on suspect when captured|
|Pennsylvania State Police had a special pair of handcuffs set aside and ready for the man wanted in the fatal shooting of one of their troopers, Cpl. Bryon Dickson.|